ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis
USA - NYSE:AQNB - US0158578080
25.63 USD
+0.04 (+0.16%)
AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. Both the profitability and financial health of AQNB have multiple concerns. AQNB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year AQNB was profitable.
In the past year AQNB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
Each year in the past 5 years AQNB had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AQNB (-10.09%) is worse than 96.00% of its industry peers.
With a Return On Equity value of -29.51%, AQNB is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
The Return On Invested Capital of AQNB (3.00%) is worse than 88.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.82%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.00%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.09% | ||
| ROE | -29.51% | ||
| ROIC | 3% |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
1.3 Margins
AQNB has a Operating Margin (20.38%) which is comparable to the rest of the industry.
AQNB's Operating Margin has declined in the last couple of years.
AQNB has a Gross Margin of 74.06%. This is in the better half of the industry: AQNB outperforms 72.00% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.38% | ||
| PM (TTM) | N/A | ||
| GM | 74.06% |
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
AQNB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AQNB has been increased compared to 5 years ago.
The debt/assets ratio for AQNB has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.31, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.31, AQNB belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
A Debt/Equity ratio of 1.29 is on the high side and indicates that AQNB has dependencies on debt financing.
The Debt to Equity ratio of AQNB (1.29) is better than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.31 |
ROIC/WACC0.42
WACC7.07%
2.3 Liquidity
AQNB has a Current Ratio of 1.09. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a Current ratio of 1.09. This is amongst the best in the industry. AQNB outperforms 88.00% of its industry peers.
AQNB has a Quick Ratio of 1.09. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQNB has a Quick ratio of 0.90. This is amongst the best in the industry. AQNB outperforms 88.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
The earnings per share for AQNB have decreased strongly by -36.00% in the last year.
The earnings per share for AQNB have been decreasing by -10.38% on average. This is quite bad
The Revenue for AQNB has decreased by -25.45% in the past year. This is quite bad
The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
3.2 Future
The Earnings Per Share is expected to grow by 6.99% on average over the next years.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y-14.99%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
EPS Next 5Y6.99%
Revenue Next Year-11.06%
Revenue Next 2Y-4.03%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 80.09, the valuation of AQNB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 92.00% of the companies listed in the same industry.
AQNB is valuated expensively when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
AQNB is valuated quite expensively with a Price/Forward Earnings ratio of 70.21.
AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, AQNB is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.09 | ||
| Fwd PE | 70.21 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.9 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.55%, AQNB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.40, AQNB has a dividend in line with its industry peers.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.55% |
5.2 History
The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.76%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079
NYSE:AQNB (10/3/2025, 8:22:56 PM)
25.63
+0.04 (+0.16%)
Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)
Earnings (Next)
Inst Owners71.48%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.68B
Analysts68.33
Price Target22.54 (-12.06%)
Short Float %0%
Short Ratio0.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.55% |
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-17.76%
Div Incr Years1
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.74%
Min EPS beat(2)-0.69%
Max EPS beat(2)42.17%
EPS beat(4)1
Avg EPS beat(4)0.15%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)0.22%
EPS beat(12)4
Avg EPS beat(12)-3.83%
EPS beat(16)5
Avg EPS beat(16)-3.04%
Revenue beat(2)2
Avg Revenue beat(2)3.06%
Min Revenue beat(2)0.82%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.41%
PT rev (1m)3.87%
PT rev (3m)6.12%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.46%
EPS NY rev (3m)6.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.09 | ||
| Fwd PE | 70.21 | ||
| P/S | 8.28 | ||
| P/FCF | N/A | ||
| P/OCF | 44.62 | ||
| P/B | 4.2 | ||
| P/tB | 5.98 | ||
| EV/EBITDA | 28.9 |
EPS(TTM)0.32
EY1.25%
EPS(NY)0.37
Fwd EY1.42%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.57
OCFY2.24%
SpS3.1
BVpS6.1
TBVpS4.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.09% | ||
| ROE | -29.51% | ||
| ROCE | 3.8% | ||
| ROIC | 3% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 3.38% | ||
| OM | 20.38% | ||
| PM (TTM) | N/A | ||
| GM | 74.06% | ||
| FCFM | N/A |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.71 | ||
| Cap/Depr | 209.43% | ||
| Cap/Sales | 36.33% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 49.18% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 1.31 |
F-Score4
WACC7.07%
ROIC/WACC0.42
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
EPS Next Y-14.99%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
EPS Next 5Y6.99%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
Revenue Next Year-11.06%
Revenue Next 2Y-4.03%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%
EBIT growth 1Y-22.44%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year40.67%
EBIT Next 3Y19.82%
EBIT Next 5YN/A
FCF growth 1Y-33.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.88%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%